Financial News Feed

Stronger Sell Today ADRO ranks #4962 as SELL CANDIDATE. Weaker Sell
Today ADRO ranks #4962 as SELL CANDIDATE.

ADRO stock Aduro Biotech

ADRO stock
Aduro Biotech

Aduro Biotech Inc. (ADRO) had a rough trading day for Friday January 18 as shares tumbled 6.25%, or a loss of $-0.18 per share, to close at $2.70. After opening the day at $2.87, shares of Aduro...

Read more

The Earnings to Price yield of Safestore Holdings plc (LSE:SAFE) is 0.093614. This is calculated by taking the earnings per share and dividing it by the last closing share price. This is one of the mo...

Read more

Unum Therapeutics (NASDAQ:UMRX) and Aduro BioTech (NASDAQ:ADRO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of th...

Read more

Aduro Biotech Inc. (ADRO) had a rough trading day for Monday January 14 as shares tumbled 5.03%, or a loss of $-0.15 per share, to close at $2.83. After opening the day at $2.97, shares of Aduro...

Read more

Checking in on some valuation rankings, Borussia Dortmund GmbH & Co. Kommanditgesellschaft auf Aktien (XTRA:BVB) has a Value Composite score of 49. Developed by James O’Shaughnessy, the VC score use...

Read more

Successful stock market traders and investors don’t usually just become that way overnight. There are often many years of experience behind those winning trades. The amount of data available to inve...

Read more

Looking at the indicators on shares of Aduro Biotech (ADRO), we see that the PPO is above the signal line. Technical traders might be on the lookout for the stock to display signs of a bullish breakou...

Read more

Triple-S Management Corporation (NYSE:GTS) has a current MF Rank of 13239. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trad...

Read more

In reviewing some key ratios and quant data for Triple-S Management Corporation (NYSE:GTS), we note that the mother of all ratios (Return on Equity) stands at -0.034356 for the firm. ROE reveals what ...

Read more

Aduro BioTech (ADRO) Stock Price Down 7%
09:50am, Friday, 11'th Jan 2019
Aduro BioTech Inc (NASDAQ:ADRO) shares were down 7% on Wednesday . The company traded as low as $2.76 and last traded at $2.77. Approximately 1,008,042 shares changed hands during trading, a decline o...

Read more

Aduro Biotech (ADRO): Tracking the Numbers
06:34pm, Thursday, 10'th Jan 2019
After a recent stock scan on shares of Aduro Biotech (ADRO), we have observed that the Percentage Price Oscillator Histogram level is over zero. Traders following the indicator may be using the readin...

Read more

In order to determine if a company is fairly valued, we can look at a number of different ratios and metrics. First off we’ll take a look at the Price to Cash Flow ratio of Aduro BioTech, Inc. (Nasd...

Read more

Aduro Biotech Inc. (ADRO) had a rough trading day for Wednesday January 09 as shares tumbled 7.05%, or a loss of $-0.21 per share, to close at $2.77. After opening the day at $2.99, shares of...

Read more

Aduro BioTech, Inc. (NasdaqGS:ADRO) currently has a current ratio of 9.32. The current ratio, which is also known as the working capital ratio, is a liquidity ratio that displays the proportion of cur...

Read more

After a recent market scan, we can see that Aduro Biotech (ADRO) shares have moved 3.47% higher over the past month. Tracking performance over the last 5 sessions, shares have moved 12.88%. Over the l...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank